PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,616,845 | -56.1% | 339,886 | -20.3% | 0.00% | -33.3% |
| Q2 2023 | $17,334,855 | -20.9% | 426,232 | -5.8% | 0.00% | -40.0% |
| Q1 2023 | $21,927,916 | +7.8% | 452,682 | -15.1% | 0.01% | 0.0% |
| Q4 2022 | $20,345,908 | -19.8% | 533,034 | +5.5% | 0.01% | -16.7% |
| Q3 2022 | $25,375,000 | +27.7% | 505,478 | +1.9% | 0.01% | +50.0% |
| Q2 2022 | $19,877,000 | +133.2% | 496,180 | +117.2% | 0.00% | +100.0% |
| Q1 2022 | $8,522,000 | -59.4% | 228,407 | -56.7% | 0.00% | -50.0% |
| Q4 2021 | $21,004,000 | +147.3% | 527,333 | +131.1% | 0.00% | +100.0% |
| Q3 2021 | $8,492,000 | -25.4% | 228,219 | -15.3% | 0.00% | -33.3% |
| Q2 2021 | $11,384,000 | -53.2% | 269,314 | -47.6% | 0.00% | -50.0% |
| Q1 2021 | $24,343,000 | -43.6% | 514,103 | -27.3% | 0.01% | -45.5% |
| Q4 2020 | $43,141,000 | +139.7% | 706,890 | +83.6% | 0.01% | +120.0% |
| Q3 2020 | $18,000,000 | -61.3% | 385,031 | -58.0% | 0.01% | -61.5% |
| Q2 2020 | $46,470,000 | +73.1% | 915,845 | +52.2% | 0.01% | +44.4% |
| Q1 2020 | $26,844,000 | +12.6% | 601,745 | +21.3% | 0.01% | +50.0% |
| Q4 2019 | $23,834,000 | +70.0% | 496,235 | +19.7% | 0.01% | +50.0% |
| Q3 2019 | $14,022,000 | -28.4% | 414,585 | -4.7% | 0.00% | -33.3% |
| Q2 2019 | $19,579,000 | -15.3% | 435,092 | -29.1% | 0.01% | -14.3% |
| Q1 2019 | $23,112,000 | +26.8% | 614,027 | +15.7% | 0.01% | +16.7% |
| Q4 2018 | $18,221,000 | -51.6% | 530,914 | -33.8% | 0.01% | -40.0% |
| Q3 2018 | $37,677,000 | +13.1% | 801,643 | -18.8% | 0.01% | +11.1% |
| Q2 2018 | $33,309,000 | +138.0% | 987,503 | +90.9% | 0.01% | +125.0% |
| Q1 2018 | $13,998,000 | +5.4% | 517,295 | -35.1% | 0.00% | +33.3% |
| Q4 2017 | $13,286,000 | +135.1% | 796,518 | +182.0% | 0.00% | +200.0% |
| Q3 2017 | $5,652,000 | +24.6% | 282,450 | +14.1% | 0.00% | 0.0% |
| Q2 2017 | $4,537,000 | -26.1% | 247,477 | -60.3% | 0.00% | -50.0% |
| Q1 2017 | $6,139,000 | +299.9% | 623,835 | +343.6% | 0.00% | – |
| Q4 2016 | $1,535,000 | -75.6% | 140,643 | -68.7% | 0.00% | -100.0% |
| Q3 2016 | $6,299,000 | +1198.8% | 449,599 | +551.4% | 0.00% | – |
| Q2 2016 | $485,000 | +491.5% | 69,023 | +441.0% | 0.00% | – |
| Q1 2016 | $82,000 | -99.3% | 12,758 | -96.3% | 0.00% | -100.0% |
| Q4 2015 | $11,131,000 | -38.6% | 343,543 | -49.4% | 0.00% | -57.1% |
| Q3 2015 | $18,115,000 | +293.0% | 678,513 | +608.5% | 0.01% | +600.0% |
| Q2 2015 | $4,610,000 | -44.2% | 95,773 | -29.5% | 0.00% | -66.7% |
| Q1 2015 | $8,262,000 | +714.8% | 135,776 | +593.3% | 0.00% | – |
| Q4 2014 | $1,014,000 | -29.0% | 19,583 | -39.7% | 0.00% | – |
| Q3 2014 | $1,428,000 | +384.1% | 32,457 | +86.5% | 0.00% | – |
| Q4 2013 | $295,000 | -49.6% | 17,407 | -36.2% | 0.00% | – |
| Q3 2013 | $585,000 | – | 27,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |